Supplemental Material_Figure.docx (175.54 kB)

Supplemental Material Figure - Real-World Clinical Outcomes of Patients With Myelofibrosis Treated With Ruxolitinib: a Medical Record Review

figure

posted on 2022-04-14, 10:44 authored by Francesco Passamonti, Florian H. Heidel, Rohan C. Parikh, Mayank Ajmera, Derek Tang, Jose Alberto Nadal, Keith L. Davis, Pranav Abraham

Supplemental Figure 1: Median Overall Survival From Ruxolitinib Based on Total Daily Dose at Initiation

Funding

Bristol-Myers Squibb

History

Usage metrics

Future Oncology

Keywords

myelofibrosis ruxolitinib survival analysis real-world data medical record review

Licence

CC BY-NC-ND 4.0